Search Results
Found 4 results
510(k) Data Aggregation
(255 days)
The Freedom® Total Knee System is indicated for the following:
• Severe knee joint pain, loss of mobility, and disability due to: rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis.
• Correction of functional deformities.
• Post-traumatic loss of knee joint contour, particularly when there is patellofemoral erosion, dysfunction, or prior patellectomy.
• Moderate valgus, varus, or flexion trauma.
• Knee fractures untreatable by other methods.
• Revision surgery where sufficient bone stock and soft tissue integrity are present (For PCK Components and Primary PCK Components only).
The Freedom® Porous Tibial Base Plate and Cementless Femoral Components are indicated for Cemented or Uncemented use. All other components are indicated for cemented use only.
The Freedom® Porous Tibial Base Plate is a line extension of the Freedom® Total Knee System comprising of tibial base plate components for cemented or uncemented use in total knee arthroplasty. Freedom® Porous Tibial Base Plates are intended for use with existing, compatible Freedom® femoral and tibial liner components. Freedom® Porous Tibial Base Plates are additively manufactured from Ti-6Al-4V ELI Grade 23 and include a porous lattice structure on the distal face. Freedom® Porous Tibial Base Plates are available in eight asymmetric design offerings (Sizes 1 – 8, Left / Right configurations), based on anterior / posterior (A/P) and medial / lateral (M/L) dimensions.
The provided document is a 510(k) premarket notification for a medical device, specifically the Freedom® Total Knee System - Porous Tibial Base Plate. This type of regulatory submission focuses on demonstrating substantial equivalence to a legally marketed predicate device rather than undergoing a de novo clinical study with strict acceptance criteria and performance analysis. Therefore, the information requested about acceptance criteria and a study proving the device meets them, typically found in a clinical trial report or a performance study for novel devices or software, is not directly applicable in the same way.
However, I can extract the information related to the non-clinical performance testing conducted to support the substantial equivalence claim. This testing serves as the "study" demonstrating that the device performs as intended and is similar to the predicate.
Here's an interpretation based on the provided text:
1. A table of acceptance criteria and the reported device performance
The document does not explicitly state numerical "acceptance criteria" for each test in the way a clinical trial might. Instead, the "acceptance" is implicitly defined by demonstrating that the subject device's performance is substantially equivalent to established performance standards or the predicate/reference devices. The "reported device performance" is summarized as the satisfactory completion of these tests.
Acceptance Criteria (Implicit) | Reported Device Performance |
---|---|
Tibial Tray Fatigue: Device must withstand fatigue loading per ASTM F1800. | All necessary testing performed. (Implies satisfactory performance meeting the standard). |
Residual Particle Characterization: Device must meet acceptable levels of residual particles per ASTM F1877, comparable to literature. | Results were shown to be substantially equivalent to values presented in the literature for the reference device (K030623). |
Porous Surface Characterization: Porous structure must meet specifications for various characteristics per ASTM F1854, F1160, F1044, F1978, F1147. | All necessary testing performed. (Implies satisfactory performance meeting the standards). |
Sterilization: Device must achieve a sterility assurance level (SAL) of 10^-6 per ISO 11137-2. | Sterilization per ISO 11137-2. (Implies successful sterilization to the required SAL). |
Endotoxin: Device must meet acceptable endotoxin levels per AAMI ST72. | Endotoxin per AAMI ST72. (Implies acceptable endotoxin levels). |
Biocompatibility: Device materials must be biocompatible per ISO 10993-1, ISO 10993-5. | Biocompatibility per ISO 10993-1, ISO 10993-5. (Implies successful demonstration of biocompatibility). |
Modular Disassembly: If applicable, modular components must meet disassembly force requirements (leveraged from reference device). | Modular disassembly testing was leveraged from the reference device (K090411) as the subject device uses an identical tibial insert locking mechanism. (Implies that the design similarity ensures equivalent performance without new testing). |
2. Sample sized used for the test set and the data provenance
- Sample Size: The document does not specify the exact number of implants or test coupons used for each non-clinical test (e.g., how many tibial trays were fatigue tested). It mentions that "All testing was performed on worst case implants or test coupons as dictated by the relevant performance standards."
- Data Provenance: The tests are non-clinical (laboratory/mechanical testing), not human clinical data. Thus, terms like "country of origin" or "retrospective/prospective" are not applicable. The data originates from laboratory testing conducted by or for the manufacturer (Maxx Orthopedics, Inc.).
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
This information is not applicable. The "test set" here refers to physical specimens (implants/coupons) for non-clinical testing, not patient data requiring expert interpretation or ground truth establishment. The "ground truth" for these tests is defined by the technical specifications and requirements of the referenced ASTM and ISO standards.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
This is not applicable as the tests are non-clinical, mechanical, and material evaluations performed against established standards, not clinical data requiring adjudication by experts.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
This is not applicable. The device is a physical knee implant, not an AI software or diagnostic tool used by human readers.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
This is not applicable. The device is a physical knee implant, not an algorithm.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)
For the non-clinical performance tests, the "ground truth" is defined by the technical specifications and requirements outlined in the referenced ASTM and ISO standards. For example, the acceptable number of cycles for fatigue testing is defined by ASTM F1800. For residual particles, the "ground truth" is the acceptable range established in the literature for the reference device, as evaluated against ASTM F1877.
8. The sample size for the training set
This is not applicable. The device is a physical knee implant. There is no "training set" in the context of machine learning or AI. The manufacturing process is validated, and the device's design is based on engineering principles and existing predicate designs, not a data-driven training set.
9. How the ground truth for the training set was established
This is not applicable for the reasons stated above.
Ask a specific question about this device
(90 days)
Smith & Nephew Total Knee Instruments are accessory devices and are intended to be used to assist in the implantation of Smith & Nephew Total Knee Systems and their cleared Indications for Use.
Indications for Cruciate Retaining Cemented Knee Replacement:
- Rheumatoid arthritis.
- Post-traumatic arthritis, osteoarthritis, or degenerative arthritis.
- Failed osteotomies, unicompartmental replacement, or total knee replacement.
Cruciate Retaining Cemented Knee components are indicated for use with cement and are single use devices.
Indications for Cruciate Retaining Cementless Knee Replacement:
- Rheumatoid arthritis.
- Post-traumatic arthritis, osteoarthritis, or degenerative arthritis.
- Failed osteotomies, unicompartmental replacement, or total knee replacement.
Cruciate Retaining Cementless Knee components are indicated for use without cement and are single use devices.
Indications for Posterior Stabilized Cemented Knee Replacement:
- Rheumatoid arthritis.
- Post-traumatic arthritis, osteoarthritis, or degenerative arthritis.
- Failed osteotomies, unicompartmental replacement, or total knee replacement.
- Primary and revision surgery, where the anterior and posterior cruciate ligaments are incompetent and the collateral ligaments remain intact.
Posterior Stabilized Cemented Knee components are indicated for use with cement and are single use devices.
Indications for Posterior Stabilized Cementless Knee Replacement:
- Rheumatoid arthritis.
- Post-traumatic arthritis, osteoarthritis, or degenerative arthritis.
- Failed osteotomies, unicompartmental replacement, or total knee replacement.
- Primary and revision surgery, where the anterior and posterior cruciate ligaments are incompetent and the collateral ligaments remain intact.
Posterior Stabilized Cementless Knee components are indicated for use without cement and are single use devices.
Indications for Constrained Total Knees:
- Rheumatoid arthritis.
- Post-traumatic arthritis, osteoarthritis, or degenerative arthritis.
- Failed osteotomies, unicompartmental replacement, or total knee replacement.
- Constrained knee systems are designed for use in patients in primary and revision surgery, where the posterior cruciate ligament and one or both of the collateral ligaments (i.e. medial collateral and/or lateral collateral ligament) are incompetent.
Constrained Total Knee components are indicated for use with cement and are single use devices.
Indications for Hinged Total Knees:
- Rheumatoid arthritis.
- Post-traumatic arthritis, osteoarthritis, or degenerative arthritis.
- Failed osteotomies, unicompartmental replacement, or total knee replacement.
- Posterior stabilized knee systems are designed for use in patients in primary and revision surgery where the anterior and posterior cruciate ligaments are incompetent and the collateral ligaments remain intact.
- Hinge knee systems are designed for use in patients in primary and revision surgery, where the posterior cruciate ligament and one or both of the collateral ligaments (i.e. medial collateral and/or lateral collateral ligament) are absent or incompetent.
Hinged Total Knee components are indicated for use with cement and are single use devices.
Subject of this Traditional 510(k) Premarket Notification are the Smith & Nephew, Inc. Total Knee System Instruments. The subject devices are accessory devices and are intended to be used to assist in the implantation of Smith & Nephew Total Knee Systems and their cleared Indications for Use. Smith & Nephew Total Knee System Instruments can be organized into instrument families which are categorized as follows: Trials, Cutting Instruments and Cutting Guides; Cutting Blocks, Alignment and Sizing Instruments, Impactors and Handles, Clamps, Extraction, Torque, Instrument Guides, and Covers and Protectors.
This document is a 510(k) Summary of Safety and Effectiveness for the Smith & Nephew Total Knee System Instruments. It explicitly states that these instruments are "accessory devices" used to assist in the implantation of Smith & Nephew Total Knee Systems.
The document does not contain any information regarding acceptance criteria or a study proving the device meets those criteria, nor does it provide details about any AI-related performance metrics.
The content is focused on:
- Device classification and regulatory information.
- Listing predicate devices (previously cleared knee systems).
- Device description (types of instruments).
- Intended use and Indications for Use for various knee replacement types (Cruciate Retaining, Posterior Stabilized, Constrained, Hinged).
- FDA clearance letter.
Therefore, I cannot provide the requested information. The document is for mechanical surgical instruments, not an AI/Software as a Medical Device (SaMD) that would typically involve performance studies with ground truth and expert reviews for diagnostic accuracy.
Ask a specific question about this device
(114 days)
The CONSENSUS® KNEE SYSTEM Primary Knee is designed as a system and is not intended for substitution of components from other systems.
- A. Primary intervention of rheumatoid arthritis, osteoarthritis, post-traumatic arthritis, or degenerative arthritis.
- B. Failed osteotomy or unicompartmental replacements.
- C. Replacement of unsatisfactory cemented or press-fit knee components when sufficient bone stock exists.
- D. The porous coated (CoCr beads with Titanium) femoral and tibial components may be used with or without cement.
The Consensus Total Knee System (CKS) is a primary fixed-bearing total knee system that has been on the market since 1990's.
The CKS has been designed to replicate the natural anatomy of the knee in order to restore knee function. It has been developed to preserve and utilize healthy ligamentous structures. For cases where the soft tissues are not functional, the PCL substituting tibial inserts or the posterior stabilized system are available for increased stability.
The CKS incorporates femoral, tibial, and patellar components and all associated instrumentation needed for implantation. The CKS can be used for total knee replacement with posterior cruciate ligament (PCL) retaining or substituting.
The femoral components are provided in left and right side versions and are designed to replicate natural kinematic motion between the femur, tibia and patella. The Consensus femoral component is designed to provide uniform contact zones in the coronal plane throughout the range of motion when the knee is properly aligned. The femoral component is also designed with a large distal radius to optimize contact areas and reduce contact stress. The trochlear groove in the femur is designed to allow the load from the patella to be evenly distributed on the femur with adequate lateral constraint.
Here's an analysis of the provided text, focusing on acceptance criteria and the study proving device performance:
Acceptance Criteria and Device Performance for Consensus® Knee System (K102927)
This submission (K102927) is primarily to expand the indications for the already cleared Consensus® Knee System (CKS) porous-coated components to allow for uncemented use. The non-clinical performance data provided specifically addresses the porous coating's mechanical and chemical properties, demonstrating its suitability for this expanded use.
1. Table of Acceptance Criteria and Reported Device Performance
The provided document includes a clear table outlining the specifications, acceptance criteria, and verification results for the modified surface (porous CoCr bead with Ti coating).
Specification | Acceptance Criteria | Verification Results |
---|---|---|
Microstructure of the modified surface | N/A | Bead to Bead Neck Diameter: 0.33 mm |
Pore Size: 0.432 mm | ||
Volume % Porosity: 37% | ||
Coating Thickness: 0.889 mm | ||
Corrosion of the modified surface (shall be equal or less than that measured in a legally marketed device) | Equal to or improved corrosion resistance when compared with CoCr beads using ASTM F746 & G61 | Critical Potential (CoCr Beads): 1290 mV; Breakdown Potential: 1200 mV |
Critical Potential (Ti Coated CoCr Beads): 1315 mV; Breakdown Potential: 1200 mV | ||
Modified surface shall exhibit adequate static tensile strength | The static tensile strength will exceed 20 MPa. | Static Tensile Strength: 58.32 MPa |
Modified surface shall exhibit adequate static shear strength | The static shear strength will exceed 20 MPa. | Static Shear Strength: 58.32 MPa |
Modified surface shall exhibit adequate shear fatigue strength | The shear fatigue strength will exceed 10 million cycles. | 10 million cycles achieved with a strength of 13.78 MPa |
Modified surface shall exhibit adequate rotating beam fatigue strength | The rotating beam fatigue strength will exceed 10 million cycles. | 10 million cycles achieved with a strength of 206.7 MPa |
Modified surface shall not exhibit excessive abrasion | N/A | 200N load: Avg. mass loss 0.006 g, Avg. thickness loss 6% |
1500N load: Avg. Mass loss 0.179 g, Avg. thickness loss 23% |
Note: For microstructure and abrasion, the "Acceptance Criteria" are listed as "N/A" in the table, indicating these are descriptive measurements rather than pass/fail thresholds in this summary. However, the reported values are provided as verification results. For corrosion, the results for both CoCr beads and Ti Coated CoCr Beads demonstrate a comparable or improved resistance against the breakdown potential.
2. Sample Size Used for the Test Set and Data Provenance
The document describes non-clinical performance data which typically involves laboratory testing of materials and components, not clinical data from patients. Therefore, terms like "test set" in the context of patient data, "country of origin of the data," or "retrospective/prospective" studies are not applicable here.
The sample sizes for the mechanical and corrosion tests are not explicitly stated in this summary. It's common in such submissions for the detailed test reports (which would include sample sizes, testing methodologies, and raw data) to be referenced but not fully reproduced in the 510(k) summary. These tests are performed on material coupons or device components in a laboratory setting.
3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications
This question is not applicable to this submission. The "test set" here refers to material samples or device components tested in a lab. The "ground truth" is established by direct physical and chemical measurements (e.g., measuring dimensions, applying forces, assessing corrosion) using standardized test methods (like ASTM standards mentioned). Therefore, human expert consensus on image interpretation or clinical outcomes is not relevant for this type of non-clinical data.
4. Adjudication Method for the Test Set
This question is not applicable. Adjudication methods (like 2+1, 3+1) are used for resolving disagreements among human experts when establishing ground truth, typically in clinical studies or image review. Since this involves non-clinical laboratory testing, there is no human adjudication process of this nature.
5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study
No MRMC study was done. This type of study assesses how human readers' diagnostic performance changes with and without AI assistance, which is irrelevant for a submission concerning the material properties and expanded uncemented use of a knee implant.
6. Standalone (Algorithm Only Without Human-in-the-Loop Performance) Study
No standalone algorithm performance study was done. This typically refers to the performance of an AI algorithm on its own. The Consensus® Knee System is a medical device (a knee implant), not an AI algorithm.
7. Type of Ground Truth Used
The ground truth used for this non-clinical performance data is direct physical and chemical measurement against predefined specifications and ASTM standards. This includes:
- Physical dimensions and morphology (e.g., bead neck diameter, pore size, coating thickness).
- Electrochemical properties (e.g., critical potential, breakdown potential for corrosion resistance).
- Mechanical properties (e.g., static tensile strength, static shear strength, shear fatigue strength, rotating beam fatigue strength, mass and thickness loss from abrasion).
8. Sample Size for the Training Set
This question is not applicable. There is no AI model or algorithm being trained within the scope of this 510(k) submission. The data presented are for validating the material properties of the porous coating.
9. How the Ground Truth for the Training Set Was Established
This question is not applicable, as there is no training set mentioned or implied in the context of this device submission.
Ask a specific question about this device
(68 days)
Total knee components are indicated for rheumatoid arthritis; post-traumatic arthritis, rolar Nrece components in older patients whose age, weight, and activity level are compatible with an adequate long-term result; failed osteotomies, unicompartmental replacement, computible intire and designed stabilized knee systems are designed for use in patients in or tolarwiso replacement. primary and revision surgery, where the anterior and posterior cruciate ligaments are absent or incompetent and the collateral ligaments remain intact.
The Profix Flex Cruciate Retaining (CR) articular insert is a single-use component intended to be used in conjunction with existing components of the Profix Total Knee System cleared for cemented use (K933958) or uncemented use (K030623).
The Profix Flex Cruciate Retaining Articular Inserts are UHMWPE tibial components which accommodate The Profix Flex Cruciate Relaining Antoclarines in Subscribers of Series flexion range. The greater lies on to those patiente with his and patellar components of the Profix Total Knee System cleared via K933958 (cemented use) and K030623 (uncemented use).
The provided text describes a medical device, the Profix Flex Cruciate Retaining Articular Insert, and its clearance process. However, it does not contain information about acceptance criteria or a study proving the device meets specific performance metrics in the context of human or AI-assisted diagnostic performance.
Instead, the document is a 510(k) premarket notification summary, which focuses on demonstrating substantial equivalence to predicate devices, primarily through mechanical testing and a comparison of design features, operational principles, and material composition.
Therefore, many of the requested sections about acceptance criteria and studies are not applicable to the provided document.
Here's an analysis based on the information provided:
Acceptance Criteria and Study for Profix Flex Cruciate Retaining Articular Insert
The provided 510(k) summary does not contain information about acceptance criteria in the context of diagnostic performance (e.g., sensitivity, specificity, accuracy) or a study evaluating such criteria. The document pertains to a medical implant and its mechanical and design equivalence, not a diagnostic or AI device.
1. Table of Acceptance Criteria and Reported Device Performance:
Acceptance Criteria (N/A for this device type) | Reported Device Performance (N/A for this device type) |
---|---|
Diagnostic performance metrics (e.g., sensitivity, specificity, accuracy) | No diagnostic performance metrics reported. |
Clinical outcomes based on human or AI-assisted interpretation | No clinical outcomes based on human or AI-assisted interpretation reported. |
Mechanical Test Data (General Statement) | "Mechanical test data indicated that the Profix Flex Cruciate Retaining Articular Insert is comparable to similar devices currently used clinically and is capable of withstanding expected in vivo loading without failure." |
2. Sample Size Used for the Test Set and Data Provenance:
- Not applicable. The document does not describe a clinical test set in the context of diagnostic performance or AI evaluation. The "mechanical test data" mentioned is not given with sample sizes or data provenance.
3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications:
- Not applicable. No expert ground truth establishment for a diagnostic test set is mentioned.
4. Adjudication Method for the Test Set:
- Not applicable. No adjudication method for a diagnostic test set is mentioned.
5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study:
- No. The document does not describe an MRMC study comparing human readers with and without AI assistance. This type of study is irrelevant to the device described (an orthopedic implant).
6. Standalone (Algorithm Only Without Human-in-the-Loop Performance) Study:
- No. The document does not describe any algorithm-only performance study. This is irrelevant to the described device.
7. Type of Ground Truth Used:
- Not applicable. No ground truth for diagnostic or AI performance is mentioned. The primary "truth" evaluated is substantial equivalence to predicate devices based on design, materials, and intended use, supported by mechanical testing results.
8. Sample Size for the Training Set:
- Not applicable. The document does not refer to a "training set" as it is not for an AI or diagnostic application.
9. How the Ground Truth for the Training Set Was Established:
- Not applicable. As there is no training set for an AI or diagnostic application, no ground truth establishment method is mentioned.
Summary of what the document does provide:
- Device Description: The Profix Flex Cruciate Retaining Articular Inserts are UHMWPE tibial components for the Profix Total Knee System.
- Intended Use: For use in patients with rheumatoid arthritis, post-traumatic arthritis, failed osteotomies, unicompartmental replacement, or total knee replacement, especially where anterior and posterior cruciate ligaments are absent or incompetent, but collateral ligaments are intact.
- Substantial Equivalence: The device's equivalence is based on similarities in indications for use, design features, operational principles, and material composition to existing predicate devices (K933958, K030623, K041825).
- Mechanical Data: There's a general statement that "Mechanical test data indicated that the Profix Flex Cruciate Retaining Articular Insert is comparable to similar devices currently used clinically and is capable of withstanding expected in vivo loading without failure." No specific data, sample sizes, or acceptance criteria for this mechanical testing are detailed in the summary.
Ask a specific question about this device
Page 1 of 1